68135-756 : Palynziq 10 mg/.5ml Subcutaneous Injection, Solution
| NDC: | 68135-756 |
| Labeler: | Biomarin Pharmaceutical Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Palynziq |
| Dosage Form: | Subcutaneous Injection, Solution |
| Application #: | BLA761079 |
| Rev. Date: |
NDC Package Codes:
- 68135-756-20: 1 SYRINGE IN 1 CARTON (68135‑756‑20) > .5 ML IN 1 SYRINGE (68135‑756‑19)
Active Ingredients:
- Pegvaliase
Dosage Strength:
- 10 mg/.5mL
Pharmaceutical Classes:
- Phenylalanine Metabolizing Enzyme [EPC]
- Phenylalanine Ammonia-Lyase [CS]
Related Products:
Based on records with the same trade name.- 68135-058 Palynziq 2.5 mg/.5ml Subcutaneous Injection, Solution by Biomarin Pharmaceutical Inc.
- 68135-673 Palynziq 20 mg/ml Subcutaneous Injection, Solution by Biomarin Pharmaceutical Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 68135-673Next: 68135-811 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.